Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Christopher Anthony Duplessis, MD

LICENSE # 0101233006
  chris.duplessis@waldenu.edu

Issue Date: 8/6/2002
Expiration Date: 12/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 12/28/2022
Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank: Instructor
Years: 5

Academic Appointments - Non-US
Last Updated 12/28/2022
None Reported
Publications
(up to ten in the last five years)
Last Updated 12/28/2022
• Bacteriophage Therapy Sterilized Refractory Pseudomonas Bacteremia in a Two Year Old
JPIDS
Volume: 7
Date: 08 2018

Evaluating the discriminating capacity of cell death (apoptotic) biomarkers in sepsis
J Intensive Care
Volume: 6
Date: 11 2018

Risk factors associated with gonorrhea and chlamydia transmission in selected health facilities in Ghana
BMC Infect Dis
Volume: 19
Date: 05 2019

Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Am J Transplant
Volume: 19
Date: 09 2019

Antimicrobial resistance (AMR) and molecular characterization of Neisseria gonorrhoeae in Ghana, 2012-2015.
PLoS One
Volume: 14
Date: 10 2019

Xanthogranulomatous pyelonephritis diagnosed in an austere environment.
Urol Case Rep
Volume: 33
Date: 07 2020

A Review of Topical Phage Therapy for Chronically Infected Wounds and Preparations for a Randomized Adaptive Clinical Trial Evaluating Topical Phage Therapy in Chronically Infected Diabetic Foot Ulcers.
Antibiotics
Volume: 9
Date: 07 2020

An Observational Study of Sepsis in Takeo Province Cambodia: An in-depth examination of pathogens causing severe infections.
Volume: 14
Date: 08 2020

Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea
Gut Microbes
Volume: 12
Date: 11 2020

Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial.
PLoS One
Volume: 15
Date: 12 2020